CFP last date
22 April 2024
Call for Paper
May Edition
IJCA solicits high quality original research papers for the upcoming May edition of the journal. The last date of research paper submission is 22 April 2024

Submit your paper
Know more
The week's pick
Responsive image
Enhancing Privacy Preservation: Multi-Attribute Protection with P-Sensitive K-Anonymity

Twinkle Patel Kiran Amin
Random Articles
Reseach Article

A Novel Framework for Predicting and Managing Comorbid Diseases using Neutrosophic Logic and Machine Learning

by A. E. Okpako, R. E. Ako
journal cover thumbnail

International Journal of Computer Applications
Foundation of Computer Science (FCS), NY, USA
Volume 175 - Number 4
Year of Publication: 2017
Authors: A. E. Okpako, R. E. Ako
10.5120/ijca2017915516

A. E. Okpako, R. E. Ako . A Novel Framework for Predicting and Managing Comorbid Diseases using Neutrosophic Logic and Machine Learning. International Journal of Computer Applications. 175, 4 ( Oct 2017), 29-36. DOI=10.5120/ijca2017915516

@article{ 10.5120/ijca2017915516,
author = { A. E. Okpako, R. E. Ako },
title = { A Novel Framework for Predicting and Managing Comorbid Diseases using Neutrosophic Logic and Machine Learning },
journal = { International Journal of Computer Applications },
issue_date = { Oct 2017 },
volume = { 175 },
number = { 4 },
month = { Oct },
year = { 2017 },
issn = { 0975-8887 },
pages = { 29-36 },
numpages = {9},
url = { https://ijcaonline.org/archives/volume175/number4/28478-2017915516/ },
doi = { 10.5120/ijca2017915516 },
publisher = {Foundation of Computer Science (FCS), NY, USA},
address = {New York, USA}
}
%0 Journal Article
%1 2024-02-07T00:24:11.354655+05:30
%A A. E. Okpako
%A R. E. Ako
%T A Novel Framework for Predicting and Managing Comorbid Diseases using Neutrosophic Logic and Machine Learning
%J International Journal of Computer Applications
%@ 0975-8887
%V 175
%N 4
%P 29-36
%D 2017
%I Foundation of Computer Science (FCS), NY, USA
Abstract

Emerging realities in medical research had advocated for a shift from single disease diagnosis mostly in clinical diagnosis of geriatric patients since most geriatric patients presents more than one disease complications. Comorbidity is visibly a phenomenon predominantly seen in elderly patients thus has made the management of diseases in such patients’ complex. A metric is needed which would be an indispensable tool for prioritizing treatment or developing clinical guidelines so as to handle the blizzards of risks of overtreatment and inappropriate prescription. This metric would provide an evidence about how both conditions and care processes interact and as such would assist and/or complement human practitioners mostly in areas where there are only General Practitioners to handle comorbid disease diagnosis , treatment and management. In this paper, we present a framework using Artificial Neural Network whose inference mechanism is driven by Neutrosophic logic, all being mechanism employed in soft computing so as to ensure intelligent capability in handling comorbidity. This framework is generic and could be used for any comorbid disease of interest.

References
  1. Abidi S.R. (2010). A Knowledge Management Framework to Develop, Model, Align and Operationalize Clinical Pathways to Provide Decision Support for Comorbid Diseases. http://dalspace.library.dal.ca/handle/ 10222/13009.
  2. Bressler R. and Bahal J.J (2003). Principles of drug therapy for elderly patients. Mayo Clin Proc; 78(12):1564–77.
  3. Chen, J.Q and Lee, S.M. (2002). An exploratory cognitive DSS for strategy decision making. Elsevier Science B.V.
  4. Ernest E. Onuiri, Oludele Awodele and Sunday A. Idowu (2014). Framework for Knowledge–Based Intelligent Clinical Decision support to Predict Comorbidity. International Journal of Advanced Research in Artificial Intelligence, (IJARAI) 3(4).
  5. Fulton M. M and Allen E.R(2005). Poly-pharmacy in elderly: a literature review. J Am Acad Nurse Pract; 17(4):123–32.
  6. Gunaratnam M. (2013). A Web-Based Perinatal Decision Support System Framework Using a Knowledge-Based-Approach to Estimate Clinical Outcomes: Neonatal Mortality and Preterm Birth in Twins Pregnancies. http://www.sce.
  7. Hajjar E.R, Cafiero A.C, and Hanlon J.T (2007). Polypharmacy in elderly patients.;Am J Geriatr Pharmacother ;5(4):345–51.
  8. Hilmer S.N, Gnjidic D.(2009). The effects of polypharmacy in older adults. Clin Pharmacol Ther;85(1):86–98.
  9. Jakovljevic Mitro and Ljerka Ostojic (2013).Comorbidity and multimorbidity in medicine today. Challenges and opportunities for bringing separated branches of medicine closer to each other. Medicinia Academica Mostrariensia, 1(1).
  10. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela S.L and Isoaho R(2002). Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol; 55(8):809–17.
  11. Mangoni A.A and Jackson S.H.D(2004). Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol; 57(1):6–14.
  12. Paolo Fraaccarro, Mercedes Arguello Casteleiro, John Ainsworth, Iain Buchan (2015). Adoption of clinical decision support in multimorbidity: a systemic review. JMIR medical Informatics 3 (1 )
  13. Power, D.J. (1999). Decision Support Systems Glossary.http://DSSResources.COM/glossary.
  14. Spinewine A, Schmader K.E, Barber N, Hughes C, Lapane K.L, Swine C, et al.(2007) Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet; 370(9582):173–84.
  15. Van den Akker M, Buntinx F, Metsemakers JFM, et al.(1998) .Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases. J Clin Epidemiol. 1998; 51:367–375.
  16. Veehof L.J.G, Meyboom-de Jong B and Haaijer-Raskamp F.M(2000). Poly-pharmacy in the elderly – a literature review. Eur J Gen Pract ;6(7):98–106.
  17. Von Lueder Thomas G. and Dan Atar (2014). Comorbidities and Polypharmacy Article in Heart Failure Clinics · April 2014.
Index Terms

Computer Science
Information Sciences

Keywords

Comorbidity Genetic Programming Neutrosophic Logic Comorbidity burden Poly-pharmacy Pathology Clinical Practice Guidelines Clinical Pathway Advanced Drug Reaction pharmacogenomics.

Powered by PhDFocusTM